Razzaghi-Asl N

References (3)

Title : Evaluation of isatin-1,3,5-triazine-benzylamine hybrids as multi-target directed ligands against Alzheimer's disease - Tamaddon-Abibigloo_2025_J.Mol.Struct_1324_140717
Author(s) : Tamaddon-Abibigloo Y , Dastmalchi S , Razzaghi-Asl N , Tuylu Kucukkilinc T , Shahbazi Mojarrad J
Ref : J Mol Struct , 1324 :140717 , 2025
Abstract :
PubMedSearch : Tamaddon-Abibigloo_2025_J.Mol.Struct_1324_140717
PubMedID:

Title : Design, synthesis, in vitro and in silico evaluations of new isatin-triazine- aniline hybrids as potent anti- Alzheimer multi-target directed lead compounds - Tamaddon-Abibigloo_2024_Bioorg.Chem_147_107355
Author(s) : Tamaddon-Abibigloo Y , Dastmalchi S , Razzaghi-Asl N , Shahbazi Mojarrad J
Ref : Bioorg Chem , 147 :107355 , 2024
Abstract :
PubMedSearch : Tamaddon-Abibigloo_2024_Bioorg.Chem_147_107355
PubMedID: 38657528

Title : Response Surface Study on Molecular Docking Simulations of Citalopram and Donepezil as Potent CNS Drugs - Alikhani_2021_Iran.J.Pharm.Res_20_560
Author(s) : Alikhani R , Ebadi A , Karami P , Shahbipour S , Razzaghi-Asl N
Ref : Iran J Pharm Res , 20 :560 , 2021
Abstract :
PubMedSearch : Alikhani_2021_Iran.J.Pharm.Res_20_560
PubMedID: 34904009